Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
560 Leser
Artikel bewerten:
(2)

Ampcera Inc.: Ampcera's All-Solid-State Battery Technology Surpasses U.S. DOE's Extreme Fast-Charging Goal of 80% Charge in 15 Minutes

Finanznachrichten News

Pioneering the Future of Fast-Charging All-Solid-State Batteries

TUCSON, AZ / ACCESSWIRE / February 15, 2024 / Ampcera Inc., a pioneer in solid-state electrolyte manufacturing and next-generation solid-state battery development, announces that its all-solid-state battery (ASSB) technology has achieved a fast-charging milestone of 0 to 80% state of charge (SOC) in under 15 minutes at a peak C-rate of 4C. This advancement demonstrates the fast-charging potential of ASSB - a key requirement for the widespread adoption of electric vehicles (EVs).

Ampcera's All-Solid-State Battery Technology Achieves Fast 80% Charge in Less Than 15 Minutes

Ampcera's All-Solid-State Battery Technology Achieves Fast 80% Charge in Less Than 15 Minutes
Charging profile (left) and capacity retention (right) of Ampcera's ASSB pouch cells under repeated fast charging

Ampcera's ASSB technology, which comprises IP-protected sulfide solid-state electrolyte materials, is engineered for extreme fast charging. A high-capacity NMC cathode and a silicon-based anode are used to achieve a high energy density goal of 400 Wh/kg. The ASSB is devoid of any liquid or semi-solid electrolyte ensuring the highest levels of battery safety, which is particularly crucial during rapid charging cycles. Lab-scale pouch cells exhibited less than 5% capacity decay after 300 cycles of repeated fast charging (4C peak C-rate) demonstrating the potential for a long cycle life of greater than 1000 cycles in commercial cells once fully developed.

"Ampcera's high-performance solid-state electrolyte materials have propelled ASSB technology beyond the U.S. Department of Energy (DOE)'s ambitious fast-charging benchmark of achieving an 80% charge in under 15 minutes," said Sumin Zhu, Co-Founder and CEO of Ampcera Inc. "Our primary objective is to introduce a commercially viable fast-charging ASSB technology that addresses consumer charge anxiety caused by extended wait times at charging stations."

The mounting concern regarding prolonged wait times at public charging stations, particularly in urban areas with limited at-home charging options, has significantly heightened charge anxiety among current and potential EV owners hindering widespread adoption. Ampcera is committed to tackling this critical challenge by advancing plans to develop and commercialize its fast-charging ASSB technology through strategic partnerships with industry leaders.

Last year, Ampcera was awarded a $2.1 million grant from the U.S. DOE's Advanced Research Projects Agency-Energy (ARPA-E) as part of the EVs4ALL program. This grant underscores Ampcera's commitment to advancing the development and commercialization of all-climate, fast-charging ASSB technology in collaboration with key industry partners, including a major U.S. automaker. It's noteworthy that achieving an 80% charge in 15 minutes or less is considered an extreme fast-charging goal for lithium batteries, as outlined by both the United States Advanced Battery Consortium (USABC) and the U.S. DOE.

About Ampcera Inc.

Ampcera is a U.S.-based innovator and global leader in the development and commercialization of solid-state electrolyte materials and scalable manufacturing processes for next-generation solid-state batteries. With over 25 U.S. and international patents and patent applications safeguarding our core technologies, we continue to lead the charge toward a sustainable energy future. Discover more about Ampcera's groundbreaking innovations at www.ampcera.com.

Contact Information

Sumin Zhu
Co-founder and CEO
info@ampcera.com
5202764565

SOURCE: Ampcera Inc.

.

View the original press release on newswire.com.

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.